This content is machine translated Multiple sclerosis Better long-term prognosis thanks to modern treatment options Over the past two decades, the arsenal of disease-modifying therapies for multiple sclerosis (MS) has expanded considerably. This applies in particular to the relapsing-remitting form (RRMS), but the treatment options...…
View Post 3 min This content is machine translated Multiple sclerosis Current treatment strategies to halt progression. In most cases, multiple sclerosis is relapsing and can progress to a chronic progressive stage over time. Which therapy management is used depends not only on the individual circumstances but also…
View Post 3 min This content is machine translated RMS and PPMS Early therapy with ocrelizumab slows the disease More than 100,000 people with MS are being treated with ocrelizumab worldwide. New analysis shows that drug exposure and low B-cell levels reduce the risk of progression. Long-term data advise…
